These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 918954)

  • 1. Effect of dialysis treatment on glucose metabolism in uremic patients.
    Kaneda H; Mimura N
    Tohoku J Exp Med; 1977 May; 122(1):35-42. PubMed ID: 918954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The response to intravenous glucose of patients on maintenance hemodialysis: effects of dialysis.
    Ferrannini E; Pilo A; Tuoni M
    Metabolism; 1979 Feb; 28(2):125-36. PubMed ID: 763147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose intolerance in uremia (A- and B-cell function during conservative and dialytic management.
    Benedetti MM; Santeusanio F; Angeletti G; Filipponi P; Buoncristiani U; Brunetti P
    Acta Diabetol Lat; 1977; 14(5-6):235-49. PubMed ID: 613688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients.
    Mak RH
    Kidney Int; 1992 Apr; 41(4):1049-54. PubMed ID: 1513086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of protein intake and dialysis on the abnormal growth hormone, glucose, and insulin homeostasis in uremia.
    Davidson MB; Fisher MB; Dabir-Vaziri N; Schaffer M
    Metabolism; 1976 Apr; 25(4):455-64. PubMed ID: 1263839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum reverse T3 assay for predicting glucose intolerance in uremic patients on dialysis therapy.
    De Marchi S; Cecchin E; Villalta D; Tesio F
    Clin Nephrol; 1987 Apr; 27(4):189-98. PubMed ID: 3581526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in insulin binding during hemodialysis in uremic patients.
    Milutinović S; Breyer D; Molnar V; Stefović A; Janković N; Skrabalo Z; Rocić B
    Nephron; 1985; 41(4):307-13. PubMed ID: 3906417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose, insulin and glucagon response to intravenous glucose load in patients on chronic hemodialysis.
    Shasha SM; Nusem D; Kanter Y; Weiner F
    Isr J Med Sci; 1988 Jan; 24(1):15-9. PubMed ID: 3279011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of carbohydrate metabolism after hemodialysis and hemofiltration in uremic patients.
    Geronemus R; Bosch JP; Thornton J; Rayfield EJ
    Arch Intern Med; 1982 Apr; 142(4):707-10. PubMed ID: 7041844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of glucose intolerance in uremia.
    DeFronzo RA
    Metabolism; 1978 Dec; 27(12 Suppl 2):1866-80. PubMed ID: 723638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-induced insulin secretion in uremia: effects of aminophylline infusion and glucose loads.
    Allegra V; Mengozzi G; Martimbianco L; Vasile A
    Kidney Int; 1990 Dec; 38(6):1146-50. PubMed ID: 1963648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin, branched-chain amino acids, and growth failure in uremia.
    Mak RH
    Pediatr Nephrol; 1998 Oct; 12(8):637-42. PubMed ID: 9811385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin resistance in the uremic patient: effects of hemodialysis].
    Sechi LA; Melis A; Pala A; Orecchioni C; Tedde R
    Boll Soc Ital Biol Sper; 1990 Oct; 66(10):993-9. PubMed ID: 2096883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperparathyroidism: is it really the major factor affecting glucose tolerance in uremia?
    Bergesio F; Bandini S; Cresci B; Monzani G; Rotella C; Conti A; Rosati A; Piperno R; Messeri G; Frizzi V; Salvadori M
    Miner Electrolyte Metab; 1996; 22(1-3):187-91. PubMed ID: 8676816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
    Alvestrand A; Mujagic M; Wajngot A; Efendic S
    Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aspects of carbohydrate metabolism in chronic uremic patients treated with periodic hemodialysis].
    Redaelli B; Salvadeo A; Ponticelli C; Imbasciati E; Graziani G
    Minerva Nefrol; 1967; 14(4):158-62. PubMed ID: 5607555
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin.
    DeFronzo RA; Tobin JD; Rowe JW; Andres R
    J Clin Invest; 1978 Aug; 62(2):425-35. PubMed ID: 353075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia.
    Mak RH
    Kidney Int; 1998 May; 53(5):1353-7. PubMed ID: 9573552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the splanchnic tissues in the pathogenesis of altered carbohydrate metabolism in patients with chronic renal failure.
    Capaldo B; Cianciaruso B; Napoli R; Andreucci V; Kopple JD; Saccà L
    J Clin Endocrinol Metab; 1990 Jan; 70(1):127-33. PubMed ID: 2403570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.